Boothbay Fund Management’s Core Laboratories CLB Stock Holding History

Boothbay Fund Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-19,166	Closed	-$722K	–	874
2019 Q4	$722K	Buy	+19,166	New	+$861K	0.06%	390
2018 Q3	–	Sell	-3,652	Closed	-$461K	–	806
2018 Q2	$461K	Sell	3,652 -968	-21%	-$118K	0.04%	368
2018 Q1	$500K	Buy	4,620 +1,548	+50%	+$171K	0.06%	321
2017 Q4	$337K	Buy	+3,072	New	+$307K	0.05%	393
2016 Q4	–	Sell	-2,541	Closed	-$285K	–	775
2016 Q3	$285K	Buy	+2,541	New	+$293K	0.06%	399
2016 Q2	–	Sell	-4,948	Closed	-$556K	–	545
2016 Q1	$556K	Buy	4,948 +1,134	+30%	+$118K	0.14%	191
2015 Q4	$415K	Buy	+3,814	New	+$437K	0.18%	160

Other funds holding CLB

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Boothbay Fund Management's CLB Position: Q1 2020 in Review

Boothbay Fund Management sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 19,166 shares — an estimated $722K sold.

Boothbay Fund Management first reported a position in CLB in Q4 2015 and held it in 7 quarters. The position peaked at $722K in Q4 2019. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.

Boothbay Fund Management reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
Boothbay Fund Management sold 19,166 Core Laboratories shares in Q1 2020, an estimated $722K.
Boothbay Fund Management first reported a position in Core Laboratories in Q4 2015 and held it in 7 quarters.
Boothbay Fund Management's Core Laboratories position peaked at $722K in Q4 2019.
207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.

Based on Boothbay Fund Management's 13F filing for Q1 2020, filed 15 May 2020.